medigraphic.com
Colegio de Medicina Interna de México.

2005, Number 1

<< Back Next >>

Med Int Mex 2005; 21 (1)

Prevalence of risk factors for heart failure in Mexico City

Orea TA, Castillo ML, Arturo Ortega SA, González TR, Morales-Olivera JM, Barrera PF

Language: Spanish
References: 19
Page: 18-31
PDF size: 88.00 Kb.


ABSTRACT

Background: Heart failure is a heterogeneous syndrome of difficult diagnosis, with increasing incidence and prevalence and whose epidemiology is little known in Mexico City.
Material and method: In order to know the prevalence of the heart failure risk factors in Mexico City, 10,000 questionnaires that included sociodemographic data, personal history, habits, comorbidities related to heart failure, signs and symptoms were filled out by individuals older than 18 years. The selection was made through a sample that was systematic and classified by age in 200 health centers (50 individuals per center) of Mexico City. The risk of heart failure was determined through a logistic regression equation.
Results: 9,564 (95.6%) questionnaires were recovered. Women constituted 75% of the sample. Among the heart failure risk factors with higher prevalence we found: obesity, high blood pressure, and type 2 diabetes mellitus. Regarding the gender, the following differences stood out: alcohol consumption (3.3 vs 23%, p ‹ 0.0001), smoking (9.4 vs 26.6%, p ‹ 0.0001), drug consumption (0.4 vs 0.9%, p = 0.02), hypertension (37.5 vs 30.7%, p ‹ 0.0001), previous myocardial infarction (1.9 vs 3.6%, p ‹ 0.0001), and obesity (57.4 vs 45.3%, p ‹ 0.0001) for women and men, respectively.
Conclusion: As heart failure is a serious problem, prevention is very important, mainly in the factors that can be modified, as the change of habits.


REFERENCES

  1. Beaglehole R, Steward AW, Jackson RT, et al. Declining rates of coronary heart disease in New Zeland and Australia, 1983-1993. Am J Epidemiol 1997;145:707.

  2. Hunink MG, Golman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease 1980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997;277:535-42.

  3. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998;352(Suppl 1):S13-17.

  4. Erikkson H. Heart failure: a growing public health problem. J Intern Med 1995;237:135-41.

  5. Mc Murray J, Hart W, Rhodes G. An evaluation of the economic cost of heart failure to the National Health Service in the United Kingdom. Br J Med Econ 1993;6:99-110.

  6. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22:6A-13A.

  7. Petrie M, Dawson N, Murdoch R, Davie A, McMurray J. Failure of women’s hearts. Circulation 1999;99:2334-41.

  8. Garavaglia GE, Messerli FH, Schmieder RE, Nunez BD, Oren S. Sex differences in cardiac adaptation to essential hypertension. Eur Heart J 1989;10:1110-4.

  9. Orea A, Castillo L, Ferez S, Ortega A. Programa Nacional de Registro de Insuficiencia Cardiaca. Resultados de un estudio multicéntrico nacional. Med Int Mex 2004;20(4):253-61.

  10. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 2002;4:531-9.

  11. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G. A national survey of heart failure in French hospitals. Eur Heart J 2000;21:763-9.

  12. Olaiz G, Rojas R, Barquera S, Shamah, T, Aguilar C, Cravioto O, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud en los adultos. Cuernavaca, Morelos, Instituto Nacional de Salud Pública, 2003.

  13. Bener A, al Suwaidi J, el-Menyar A, Gehani A. The effect of hypertension as a predictor of risk for congestive heart failure patients over a 10-year period in a newly developed country. Blood Press 2004;13(1):41-46.

  14. Shindler MD, Kostis JB, Quinones MA, Pitt B, Stewart D, Pinkett T, et al. Diabetes mellitus: a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996;77:1017-20.

  15. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 2004;27(8):1879-84.

  16. Piccini JP, Klein L, Gheorghiade M, Bonow RO. New insights into diastolic heart failure: role of diabetes mellitus. Am J Med 2004;116(Suppl 5A):64S-75S.

  17. Scaglione R, Argano C, Di Chiara T, Licata G. Obesity and cardiovascular risk: the new public health problem of worldwide proportions. Expert Rev Cardiovasc Ther 2004;2(2):203-12.

  18. Valencia M, Orea A, Castaño VA, Resendiz M, Rosales M, Rebollar V, et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res 2000;8:262-9.

  19. Valencia FM, Rebollar GV, Santiago V, Orea TA, Rodríguez C, Resendiz M, et al. Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude. Int J Obes Relat Metab Disord 2004;28(9):1174-80.




2020     |     www.medigraphic.com